Robert F. Kennedy Jr. has again drawn on dubious research to promote misinformation, particularly regarding the safety of mifepristone. At a Senate Committee hearing, he cited a problematic study to argue for an FDA review of the drug, which is commonly used in abortions. This study, released by the Ethics and Public Policy Center, lacks scientific credibility, deviating significantly from health research standards. Kennedy's willingness to base official health guidance on such flawed evidence raises serious questions about the integrity of public health policies.
Kennedy is prepared to rework official guidance on a widely used drug, based on a poorly designed report that has not undergone peer review.
The EPPC report claims mifepristone is dangerous despite contradicting decades of global trials conducted by health experts.
Collection
[
|
...
]